100% Verified Answers
100 Questions | 2026-2027 | 100% VERIFIED
Introduction
This verified question bank prepares advanced nursing professionals for the 3P examination in
pharmacology, pathophysiology, and physical assessment and for the clinical execution of advanced
nursing care. Content follows the eight domains of the certification blueprint: Advanced
Pharmacology and Therapeutics; Advanced Pathophysiology and Disease Processes;
Comprehensive Physical Assessment and Health History; Clinical Decision Making and Diagnostic
Reasoning; Health Promotion and Disease Prevention; Evidence-Based Guidelines and Clinical
Operations; Professional Ethics and Legal Standards; and Interprofessional Collaboration and
Healthcare Delivery. Every item presents four distinct options, the correct answer, and a concise
rationale explaining the underlying reasoning and why the remaining options are incorrect.
Mastery of this content is essential for professional certification and advanced nursing clinical
execution, where sound diagnostic reasoning, safe therapeutics, and disciplined professional
judgment determine patient outcomes.
1. Which principle explains why an oral drug with extensive first-pass metabolism has low
bioavailability?
A. Absorbed drug binds to plasma proteins so completely that no free drug remains
B. Absorbed drug is metabolized in the intestinal wall and liver before reaching systemic
circulation, reducing the fraction that reaches target tissue
C. Absorbed drug is excreted unchanged by the kidneys before it can act
D. Absorbed drug is degraded by gastric acid into inactive fragments only
Answer: B. Absorbed drug is metabolized in the intestinal wall and liver before reaching
systemic circulation, reducing the fraction that reaches target tissue
Rationale: Presystemic hepatic and intestinal metabolism reduces the amount of active drug
entering systemic circulation. Protein binding, renal elimination of unchanged drug, and acid
degradation describe different pharmacokinetic processes with different clinical consequences.
2. A patient taking a medication metabolized by cytochrome P450 3A4 begins a strong inhibitor of
that enzyme. What is the expected result?
A. Serum concentration of the substrate falls, reducing therapeutic effect
B. The substrate is converted to a more active metabolite with no accumulation
C. Serum concentration of the substrate rises, increasing the risk of dose-related toxicity
D. The inhibitor increases renal excretion of the substrate and shortens its action
, Answer: C. Serum concentration of the substrate rises, increasing the risk of dose-related
toxicity
Rationale: Inhibition slows oxidative metabolism of the substrate, so accumulation with
toxicity is likely and dose adjustment or substitution is required. Reduced concentration,
increased activation, and enhanced renal excretion describe induction or different elimination
pathways rather than enzyme inhibition.
3. Which drug has a narrow therapeutic index and therefore requires routine serum concentration
monitoring?
A. Amoxicillin
B. Acetaminophen at standard doses
C. Loratadine
D. Digoxin
Answer: D. Digoxin
Rationale: Narrow therapeutic index drugs such as digoxin produce toxicity near their
therapeutic range, so concentrations are measured and doses individualized. Amoxicillin,
standard-dose acetaminophen, and loratadine have wide margins of safety and do not require
routine level monitoring.
4. Which consideration determines whether a beta blocker is appropriate for a patient with reactive
airway disease?
A. All beta blockers are equally safe because the effect depends only on the dose
B. Cardioselective agents at low doses are less likely to provoke bronchospasm than
nonselective agents that block beta-2 receptors
C. Beta blockers improve bronchial airflow and are indicated in acute bronchospasm
D. Selectivity matters only when the patient also takes a diuretic
Answer: B. Cardioselective agents at low doses are less likely to provoke bronchospasm
than nonselective agents that block beta-2 receptors
Rationale: Bronchodilation depends on beta-2 receptor stimulation, so nonselective blockade
risks bronchospasm while cardioselective drugs spare the airway at lower doses. Claiming
equal safety, describing benefit in bronchospasm, and limiting selectivity concerns to diuretic
use misstate the pharmacology.
5. Which adverse effect is most characteristic of angiotensin-converting enzyme inhibitor therapy?
A. Hypernatremia with peripheral edema from sodium retention
B. A persistent dry cough from bradykinin accumulation, with hyperkalemia and rising
creatinine also requiring monitoring
C. Hyperglycemia requiring insulin adjustment in most patients
D. Thrombocytopenia with bleeding requiring platelet transfusion
Answer: B. A persistent dry cough from bradykinin accumulation, with hyperkalemia
and rising creatinine also requiring monitoring
, Rationale: ACE inhibition raises bradykinin concentrations, producing cough, and reduces
aldosterone, raising potassium. Sodium retention, hyperglycemia, and thrombocytopenia are
not the classic effects of this drug class.
6. Why must long-term systemic corticosteroid therapy be tapered rather than stopped abruptly?
A. Abrupt withdrawal causes immediate hypersensitivity to the drug itself
B. Tapering prevents the drug from being excreted too rapidly by the kidneys
C. Tapering is required only to prevent weight gain after treatment ends
D. Suppression of the hypothalamic-pituitary-adrenal axis requires gradual withdrawal to
allow endogenous cortisol production to recover
Answer: D. Suppression of the hypothalamic-pituitary-adrenal axis requires gradual
withdrawal to allow endogenous cortisol production to recover
Rationale: Prolonged exogenous steroid exposure suppresses adrenal output, so abrupt
cessation risks adrenal crisis. Hypersensitivity, renal excretion rate, and weight gain are not
the reasons for tapering.
7. How does physical dependence differ from addiction in a patient receiving long-term opioid
therapy?
A. The terms are interchangeable and describe the same clinical phenomenon
B. Physical dependence always progresses to addiction within one year of therapy
C. Physical dependence is an expected physiologic adaptation with withdrawal on abrupt
cessation, while addiction involves compulsive use despite harm
D. Addiction develops only in patients who use illicit substances
Answer: C. Physical dependence is an expected physiologic adaptation with withdrawal
on abrupt cessation, while addiction involves compulsive use despite harm
Rationale: Dependence reflects receptor adaptation that can occur with appropriate
prescribing, whereas addiction involves impaired control and continued use despite
consequences. Equating the terms, predicting inevitable progression, and limiting addiction to
illicit use misstate the distinction.
8. Which factor converts a patient's creatinine clearance into a critical dosing consideration?
A. Renal function affects only drugs given orally
B. Reduced renal clearance allows renally eliminated drugs to accumulate, so doses or intervals
must be adjusted
C. Renal impairment increases hepatic metabolism and eliminates the need for adjustment
D. Renal function is relevant only for antibiotics
Answer: B. Reduced renal clearance allows renally eliminated drugs to accumulate, so
doses or intervals must be adjusted
Rationale: Kidneys clear many drugs and metabolites, so falling function requires dose
reduction or interval extension to prevent toxicity. Limiting the concern to oral agents or
antibiotics and expecting enhanced hepatic clearance are incorrect assumptions.
, 9. Which monitoring plan best reflects the pharmacology of warfarin therapy?
A. Routine aPTT monitoring because warfarin affects the intrinsic pathway
B. Regular international normalized ratio testing with attention to diet, drug interactions, and
bleeding signs
C. Platelet count monitoring alone at annual intervals
D. Serum drug level measurement at every visit
Answer: B. Regular international normalized ratio testing with attention to diet, drug
interactions, and bleeding signs
Rationale: Warfarin inhibits vitamin K-dependent factors and is monitored with the
international normalized ratio, with vitamin K intake and interacting drugs affecting stability.
The aPTT reflects heparin effect, platelet counts do not measure warfarin response, and serum
levels are not used.
10. Which adverse effect of statin therapy requires prompt evaluation?
A. Mild transient nausea during the first week of therapy
B. Increased appetite with weight gain
C. Loss of taste for sweet foods
D. Unexplained muscle pain or weakness with dark urine, suggesting myopathy or
rhabdomyolysis
Answer: D. Unexplained muscle pain or weakness with dark urine, suggesting myopathy
or rhabdomyolysis
Rationale: Muscle symptoms with pigmenturia suggest significant muscle injury that requires
creatine kinase measurement and drug discontinuation. Transient nausea, appetite change,
and taste alteration are not the serious effects associated with this class.
11. Why does the Beers criteria assist prescribing for older adults?
A. It identifies medications whose risks generally outweigh benefits in older adults, supporting
safer alternatives and dose reduction
B. It lists drugs that are contraindicated in every patient over age 65
C. It replaces clinical judgment with fixed dosing for all older patients
D. It applies only to patients residing in long-term care facilities
Answer: A. It identifies medications whose risks generally outweigh benefits in older
adults, supporting safer alternatives and dose reduction
Rationale: The criteria highlight potentially inappropriate medications for older adults as a
decision aid rather than an absolute prohibition. Universal contraindication, substitution for
clinical judgment, and restriction to facility residents misrepresent its purpose and use.
12. Which principle underlies weight-based dosing in children?
A. Drug distribution, hepatic metabolism, and renal clearance vary with age and body size, so
doses are calculated per kilogram with age-specific limits